The supply of Covaxin was suspended following a WHO inspection for emergency use list between 14 and 22 March. (Image: REUTERS/Adnan Abidi)
Foreign Ministry spokesman Arindam Bagchi said there was no question on the vaccine’s effectiveness and the World Health Organization’s decision should not be a cause for concern.
- PTI new Delhi
- Last Update:April 08, 2022, 00:00 IST
- Follow us on:
Days after the WHO suspended the supply of covaccine through UN procurement agencies, India on Thursday said the move would not affect the travel of those who have taken the vaccine. Foreign Ministry spokesman Arindam Bagchi said there is no question on the vaccine’s effectiveness and the decision of the World Health Organization (WHO) should not be a cause for concern.
“I certainly don’t think it should have any effect on people taking Covaxin. It’s a safe vaccine. In terms of their travel, it’s recognized under the WHO’s EUL (emergency use authorization),” he said. . Bagchi was answering questions on the WHO’s decision.
“Various countries have already accepted it. We have also achieved mutual recognition of vaccination certificate arrangements with various countries.
Bagchi said his understanding was that the efficacy of the vaccine was not in question and that there is something about process issues that are being worked out by the company and the WHO. A statement issued by the WHO on Saturday said the suspension was the result of subsequent EUL (emergency use authorization) inspections and the need for process and facility upgrades to address the recently identified GMP (good construction practice) deficiencies. is in response to.
read all Breaking News , today’s fresh news And IPL 2022 Live Updates Here.